1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance

2. Europe Vaccines Market – Key Takeaways

3. Europe Vaccines Market – Market Landscape
3.1 overview
3.2 Market Segmentation
3.2.1 Europe Vaccines Market – By Technology
3.2.2 Europe Market – By Disease Indication
3.2.3 Europe Vaccines Market – By Route of Administration
3.2.4 Europe Vaccines Market – By Patient Type
3.2.5 Europe Vaccines Market – By Country
3.3 PEST Analysis

4. Europe Vaccines Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Growing Awareness Programs for Vaccination in Europe
4.1.2 Increasing Vaccines Research and Development Activities in Europe.
4.2 Key Market Restraints
4.2.1 Vaccines Hesitancy in the European region.
4.3 Key Market Opportunities
4.3.1 Growing Prevalence of Infectious Diseases
4.4 Future Trends
4.4.1 New Vaccines In Development
4.5 Impact Analysis

5. Vaccines Market – Europe Analysis
5.1 Europe Vaccines Market Revenue Forecasts and Analysis
5.2 Market Positioning
5.3 Performance of Key Players
5.3.1 Sanofi

6. Europe Vaccines Market Analysis – By Technology
6.1 Overview
6.2 Europe Vaccines Market, By Type, 2018 & 2027 (%)
6.3 Europe Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
6.4 Europe Recombinant Vaccines Market
6.4.1 Overview
6.4.2 Europe Recombinant Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Europe Conjugate Vaccines Market
6.5.1 Overview
6.5.2 Europe Conjugate Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
6.6 Europe Live Attenuated Vaccines Market
6.6.1 Overview
6.6.2 Europe Live Attenuated Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
6.7 Europe Inactivated Vaccines Market
6.7.1 Overview
6.7.2 Europe Inactivated Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
6.8 Europe Toxoid Vaccines Market
6.8.1 Overview
6.8.2 Europe Toxoid Vaccines Market Revenue and Forecast to 2027 (US$ Mn)

7. Europe Vaccines Market Analysis – By Disease Indication
7.1 Overview
7.2 Europe Vaccines Market, By Disease Indication, 2018 & 2027 (%)
7.3 Europe Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
7.4 Europe DTP (Diphtheria, Tetanus, And Pertussis) Market
7.4.1 Overview
7.4.2 Europe DTP (Diphtheria, Tetanus, And Pertussis) Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Europe Influenza Market
7.5.1 Overview
7.5.2 Europe Influenza Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Europe Hepatitis Market
7.6.1 Overview
7.6.2 Europe Hepatitis Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Europe Other Diseases Market
7.7.1 Overview
7.7.2 Europe Other Diseases Market Revenue and Forecast to 2027 (US$ Mn)

8. Europe Vaccines Market Analysis – By Route of Administration
8.1 Overview
8.2 Europe Vaccines Market, By Route of Administration, 2018 & 2027 (%)
8.3 Europe Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
8.4 Europe Oral Market
8.4.1 Overview
8.4.2 Europe Oral Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Europe Injectable Market
8.5.1 Overview
8.5.2 Europe Injectable Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Europe Other Routes of Administration Market
8.6.1 Overview
8.6.2 Europe Other Routes of Administration Market Revenue and Forecast to 2027 (US$ Mn)

9. Europe Vaccines Market Analysis – By Patient Type
9.1 Overview
9.2 Europe Vaccines Market, By Patient Type, 2018 & 2027 (%)
9.3 Europe Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
9.4 Europe Pediatric Market
9.4.1 Overview
9.4.2 Europe Pediatric Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Europe Adults Market
9.5.1 Overview
9.5.2 Europe Adults Market Revenue and Forecast to 2027 (US$ Mn)

10. Europe Vaccines Market Revenue And Forecasts To 2027
10.1.1 Europe Vaccines Market Revenue Overview, by Country (2017) (US$ Mn)
10.1.2 Europe Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.3 Europe Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.4 Europe Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.5 Europe Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.6 Europe Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.7 Europe Vaccines Market Revenue and Forecasts to 2027, By Country (%)
10.1.8 Germany Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9 Germany Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.1 Germany Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.9.2 Germany Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.9.3 Germany Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.9.4 Germany Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.10 UK Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.11 UK Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.11.1 UK Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.11.2 UK Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.11.3 UK Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.11.4 UK Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.12 France Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.13 France Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.13.1 France Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.13.2 France Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.13.3 France Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.13.4 France Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.14 Italy Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.15 Italy Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.15.1 Italy Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.15.2 Italy Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.15.3 Italy Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.15.4 Italy Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.16 Spain Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.17 Spain Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.17.1 Spain Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.17.2 Spain Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.17.3 Spain Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.17.4 Spain Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

11. Vaccines Market –Industry Landscape
11.1 Overview
11.2 Comparative Company Analysis
11.3 Growth Strategies Done by the Companies in the Market, (%)
11.4 Organic Developments
11.4.1 Overview
11.5 Inorganic Developments
11.5.1 Overview

12. Vaccines Market–Key Company Profiles
12.1 Pfizer Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 GlaxoSmithKline plc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merck & Co., Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sanofi
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Information
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Johnson & Johnson Services, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Panacea Biotic Limited
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Information
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Astellas Pharma Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 Swot Analysis
12.7.6 Key Developments
12.8 NOVAVAX, INC.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Information
12.8.4 Product Pipeline
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 VBI Vaccines Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Information
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 BAVARIAN NORDIC
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Information
12.10.4 Product Pipeline
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
13.3 Methodology
13.3.1 Coverage
13.3.2 Secondary Research
13.3.3 Primary Research

Figure 1. Germany Vaccines Market, Revenue (US$ Mn), By Country 2018 & 2027
Figure 2. Europe Vaccines Market By Type, Market Share (%), 2018
Figure 3. Europe Vaccines Market By Disease indication, Market Share (%), 2018
Figure 4. Europe Vaccines Market By Route of Administration, Market Share (%), 2018
Figure 5. Europe Vaccines Market By Patient Type, Market Share (%), 2018
Figure 6. Vaccines Market Segmentation
Figure 7. Europe PEST Analysis
Figure 8. Vaccines Market Impact Analysis of Drivers & Restraints
Figure 9. Europe Vaccines Market – Revenue Forecasts and Analysis – 2018- 2027
Figure 10. Europe Vaccines Market, By Technology, 2018 & 2027 (%)
Figure 11. Europe Recombinant Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Europe Conjugate Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Europe Live Attenuated Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Europe Inactivated Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Europe Toxoid Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Europe Vaccines Market By Disease Indication, 2017 & 2025 (%)
Figure 17. Europe DTP (Diphtheria, Tetanus, And Pertussis) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Europe Influenza Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Europe Hepatitis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Europe Other Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Europe Vaccines Market By Route of Administration, 2018 & 2027 (%)
Figure 22. Europe Oral Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Europe Injectable Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Europe Other Routes of Administration Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Europe Vaccines Market By Patient Type, 2018 & 2027 (%)
Figure 26. Europe Pediatric Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Europe Adults Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Europe Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Europe Vaccines Market Revenue And Forecasts to 2027, By Country (%)
Figure 30. Germany Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. UK Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 32. France Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 33. Italy Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 34. Spain Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 35. Comparative Company Analysis
Figure 36. Growth Strategies Done by the Companies in the Market, (%)

Table 1. Europe Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 2. Europe Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 3. Europe Vaccines Market Revenue And Forecasts to 2027, By route of administration (US$ Mn)
Table 4. Europe Vaccines Market Revenue And Forecasts to 2027, By patient type (US$ Mn)
Table 5. Europe Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 6. Europe Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 7. Europe Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
Table 8. Europe Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
Table 9. Germany Vaccines Market Revenue And Forecasts To 2027, By Technology (US$ Mn)
Table 10. Germany Vaccines Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
Table 11. Germany Vaccines Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 12. Germany Vaccines Market Revenue And Forecasts To 2027, By Patient Type (US$ Mn)
Table 13. UK Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 14. UK Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 15. UK Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
Table 16. UK Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
Table 17. France Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 18. France Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 19. France Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
Table 20. France Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
Table 21. Italy Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 22. Italy Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 23. Italy Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
Table 24. Italy Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
Table 25. Spain Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 26. Spain Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 27. Spain Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
Table 28. Spain Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
Table 29. Organic Developments Done By Companies
Table 30. Inorganic Developments Done by Companies
Table 31. Glossary of Terms, Vaccines market

The List of Companies
1. PFIZER INC
2. GlaxoSmithKline plc.
3. Merck & Co., Inc.
4. Sanofi
5. Johnson & Johnson Services, Inc.
6. Panacea Biotic Limited
7. Astellas Pharma Inc.
8. NOVAVAX, INC.
9. VBI Vaccines Inc.
10. Bavarian Nordic